| Trial ID: | L1773 |
| Source ID: | NCT00675220
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Delivery Systems
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Safety profile of Insulin Aspart among Filipino patients, 1-month follow-up for outpatients; 1 month or upon discharge for inpatients whichever comes first |
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
373
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-06
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Manilla, 1605, Philippines
|
| URL: |
https://clinicaltrials.gov/show/NCT00675220
|
